These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25157661)

  • 1. The interaction of quaternary reversible acetylcholinesterase inhibitors with the nicotinic receptor.
    Sepsova V; Krusek J; Zdarova Karasova J; Zemek F; Musilek K; Kuca K; Soukup O
    Physiol Res; 2014; 63(6):771-7. PubMed ID: 25157661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.
    Komloova M; Musilek K; Dolezal M; Gunn-Moore F; Kuca K
    Curr Med Chem; 2010; 17(17):1810-24. PubMed ID: 20345342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Multitarget Molecules Derived from Caffeine as Potentiators of the Cholinergic System.
    Munafó JP; Biscussi B; Obiol D; Costabel M; Bouzat C; Murray AP; Antollini S
    ACS Chem Neurosci; 2024 Mar; 15(5):994-1009. PubMed ID: 38407056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinities of bispyridinium non-oxime compounds to [(3)H]epibatidine binding sites of Torpedo californica nicotinic acetylcholine receptors depend on linker length.
    Niessen KV; Seeger T; Tattersall JE; Timperley CM; Bird M; Green C; Thiermann H; Worek F
    Chem Biol Interact; 2013 Dec; 206(3):545-54. PubMed ID: 24157926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tissue-specific acetylcholinesterase inhibitor C-547 on α3β4 and αβεδ acetylcholine receptors in COS cells.
    Lindovský J; Petrov K; Krůšek J; Reznik VS; Nikolsky EE; Vyskočil F
    Eur J Pharmacol; 2012 Aug; 688(1-3):22-6. PubMed ID: 22634638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission.
    Pereira DM; Ferreres F; Oliveira JM; Gaspar L; Faria J; Valentão P; Sottomayor M; Andrade PB
    Phytomedicine; 2010 Jul; 17(8-9):646-52. PubMed ID: 19962870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
    Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective effects of carbamate pesticides on rat neuronal nicotinic acetylcholine receptors and rat brain acetylcholinesterase.
    Smulders CJ; Bueters TJ; Van Kleef RG; Vijverberg HP
    Toxicol Appl Pharmacol; 2003 Dec; 193(2):139-46. PubMed ID: 14644616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR.
    Samochocki M; Zerlin M; Jostock R; Groot Kormelink PJ; Luyten WH; Albuquerque EX; Maelicke A
    Acta Neurol Scand Suppl; 2000; 176():68-73. PubMed ID: 11261808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physostigmine blocked nicotinic acetylcholine receptors in rat sympathetic ganglion neurons.
    Zheng JQ; He XP; Yang AZ; Liu CG
    Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):508-11. PubMed ID: 10322906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counteracting desensitization of human α7-nicotinic acetylcholine receptors with bispyridinium compounds as an approach against organophosphorus poisoning.
    Scheffel C; Niessen KV; Rappenglück S; Wanner KT; Thiermann H; Worek F; Seeger T
    Toxicol Lett; 2018 Sep; 293():149-156. PubMed ID: 29248576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinesterase induces nicotinic receptor modulation.
    Sung JJ; Kim SJ; Lee HB; Chung JM; Choi YM; Cha CI; Suh YH; Lee KW
    Muscle Nerve; 1998 Sep; 21(9):1135-44. PubMed ID: 9703439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine modulation of acetylcholine currents in COS cells transfected with mouse muscle nicotinic receptor.
    Svobodová L; Krůsek J; Hendrych T; Vyskocil F
    Neurosci Lett; 2006 Jun; 401(1-2):20-4. PubMed ID: 16530961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterase inhibitors in MG: to be or not to be?
    Punga AR; Stålberg E
    Muscle Nerve; 2009 Jun; 39(6):724-8. PubMed ID: 19260048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block of neuronal nicotinic acetylcholine receptors by organophosphate insecticides.
    Smulders CJ; Bueters TJ; Vailati S; van Kleef RG; Vijverberg HP
    Toxicol Sci; 2004 Dec; 82(2):545-54. PubMed ID: 15342957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Block of recombinant nicotinic receptor channels by IgG from myasthenic patients.
    Krampfl K; Dengler R; Bufler J
    Muscle Nerve; 2002 Mar; 25(3):433-7. PubMed ID: 11870722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
    Musilek K; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K
    Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel peptide modulates alpha7 nicotinic receptor responses: implications for a possible trophic-toxic mechanism within the brain.
    Greenfield SA; Day T; Mann EO; Bermudez I
    J Neurochem; 2004 Jul; 90(2):325-31. PubMed ID: 15228589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acetylcholinesterase inhibitor BW284c51 is a potent blocker of Torpedo nicotinic AchRs incorporated into the Xenopus oocyte membrane.
    Olivera-Bravo S; Ivorra I; Morales A
    Br J Pharmacol; 2005 Jan; 144(1):88-97. PubMed ID: 15644872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptors.
    Marco JL; de los Ríos C; García AG; Villarroya M; Carreiras MC; Martins C; Eleutério A; Morreale A; Orozco M; Luque FJ
    Bioorg Med Chem; 2004 May; 12(9):2199-218. PubMed ID: 15080920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.